drugset / Trial / NCT06365632
Clinical Study of the Effectiveness, Tolerability and Safety of the Drug "Anti-spike, Gel, 100 g in Bottles in Package No. 1" Produced by the Republican Unitary Enterprise "Unitekhprom BSU", With a Single Intraperitoneal Use After Surgery in Adult Patients With Acute Phlegmonous Appendicitis
Phase 2
Active not recruiting
100 enrolled
Research Institute for Physical Chemical Problems of the Belarusian State University
City Clinical Hospital of Emergency Medical Care of Minsk · collabUnitary Enterprise UNITEHPROM BSU · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of the clinical trials is the evaluation of the effectiveness and safety of a single intraperitoneal use of the drug "Antispike, gel, 100 g in a bottle" produced by Unitary Enterprise Unitehprom BSU, Belarus in patients after surgical control of acute phlegmonous appendicitis to prevent abdominal adhesions.
Timeline
- Start
- 2025-03-19
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Antispike | Unknown | — | Intrathecal |
Indications
No indication recorded.